KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Return on Sales (2017 - 2025)

Guardant Health's Return on Sales history spans 9 years, with the latest figure at 0.46% for Q4 2025.

  • For Q4 2025, Return on Sales rose 9.0% year-over-year to 0.46%; the TTM value through Dec 2025 reached 0.42%, up 17.0%, while the annual FY2025 figure was 0.42%, 17.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.46% at Guardant Health, down from 0.35% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.35% in Q3 2025 and bottomed at 2.1% in Q2 2022.
  • The 5-year median for Return on Sales is 0.68% (2021), against an average of 0.88%.
  • The largest annual shift saw Return on Sales crashed -104bps in 2022 before it soared 157bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.67% in 2021, then tumbled by -65bps to 1.1% in 2022, then dropped by -9bps to 1.21% in 2023, then surged by 54bps to 0.55% in 2024, then increased by 17bps to 0.46% in 2025.
  • Per Business Quant, the three most recent readings for GH's Return on Sales are 0.46% (Q4 2025), 0.35% (Q3 2025), and 0.43% (Q2 2025).